cvd 1208s
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2010 (NCT00866242)
Timeline
Indications
Studied for
Mechanism of action
- Heat-stable enterotoxin receptorImmunity, active
GUCY2C immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cvd 1208s
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01531530 | Phase 1 | Jul 1, 2011 | PATH, University of Maryland |
| NCT00866242 | Phase 2 | Jan 1, 2010 | PATH, University of Maryland |
| NCT00866476 | Phase 2 | Jan 1, 2010 | PATH, University of Maryland |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PATH | Academic/Hospital | 3 | 0 | 2 | 2010 |
| University of Maryland | Academic/Hospital | 3 | 3 | 2 | 2010 |
2 organizations
Page 1 / 1